Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Escalon MedicalESMC 34 Median PS Value is $0.13 as of Jul. 23, 2026, which is 74% below its 10-year median of 0.50. GuruFocus rates ESMC with a GF Score™ of 34/100 and a GF Value™ of $0.15 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 335 Medical Devices & Instruments companies, Escalon Medical ranks worse than 90.15% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
As of today (2026-07-23), Escalon Medical's share price is $0.20. Escalon Medical's Median PS Value is $0.13. Therefore, Escalon Medical's Price to Median PS Value for today is 1.54.
The historical rank and industry rank for Escalon Medical's Median PS Value or its related term are showing as below:
ESMC'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.14 Med: 0.5 Max: 2.49
Current: 1.54
During the past 13 years, the highest Price to Median PS Value of Escalon Medical was 2.49. The lowest was 0.14. And the median was 0.50.
ESMC's Price-to-Median-PS-Value is ranked worse than 90.15% of 335
companies
in the Medical Devices & Instruments industry
Industry Median: 0.7
vs ESMC: 1.54
Escalon Medical (OTCPK:ESMC) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Escalon Medical's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.20
/
0.13
=
1.54
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Escalon Medical Median PS Value Related Terms
Escalon Medical Median PS Value Historical Data
* Premium members only.
The historical data trend for Escalon Medical's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ESMC vs RBOT, NUWE, NUMD: Median PS Value Comparison
For the Medical Devices subindustry, Escalon Medical's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Escalon Medical Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Escalon Medical's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Escalon Medical's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.1344.
Escalon Medical's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.967.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Escalon Medical (ESMC) has a Median PS Value of $0.13 as of Jul. 23, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Escalon Medical and its competitors. This is 74% below median its historical median of 0.50. Over the past decade, Escalon Medical's Median PS Value has ranged from 0.14 to 2.49. According to the industry distribution chart, Escalon Medical ranks #302 out of 335 companies in the Medical Devices & Instruments industry, placing it in the top 90.1%.
Is Escalon Medical's Median PS Value too high?
Escalon Medical's current Median PS Value of $0.13 is 74% below median its 10-year median of 0.50. Over the past 10 years, this metric has ranged from a low of 0.14 to a high of 2.49. The Medical Devices & Instruments industry median Median PS Value is 0.70. Escalon Medical's value of $0.13 is 81.4% below this industry median. Based on the distribution chart, Escalon Medical ranks #302 out of 335 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Escalon Medical has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Escalon Medical's Median PS Value compare to RBOT and NUWE?
According to the Medical Devices & Instruments industry distribution chart, Escalon Medical ranks #302 out of 335 companies for Median PS Value. This places Escalon Medical in the lower half of its industry. The industry median Median PS Value is 0.70. Escalon Medical's value of $0.13 is 81.4% below this benchmark. Historically, Escalon Medical's own Median PS Value has ranged from 0.14 to 2.49 over the past decade. While the company's 10-year median is 0.50 vs. the industry median of 0.70, Escalon Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.70, based on 335 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Escalon Medical's current Median PS Value of $0.13 is 81.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Escalon Medical and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Escalon Medical's current Median PS Value is $0.13, which is 74% below median its own 10-year median of 0.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Escalon Medical stock overvalued right now?
Based on GuruFocus' analysis, Escalon Medical (ESMC) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.15, compared to a current price of $0.20 — trading 33.3% above its estimated fair value. The current Median PS Value is $0.13, which is 74% below median its 10-year median of 0.50 and 81.4% below the Medical Devices & Instruments industry median of 0.70. Escalon Medical's overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Escalon Medical (ESMC), the current Median PS Value is $0.13 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Escalon Medical (ESMC) Overvalued in 2026?
Based on GuruFocus' analysis, Escalon Medical stock appears to be overvalued.
The current stock price of $0.20 is trading 33.3% above its estimated GF Value™ of $0.15.
GuruFocus considers Escalon Medical to be Significantly Overvalued.
Key valuation signals for ESMC:
Median PS Value: $0.13 (74% below median its 10-year median of 0.50)
GF Value™: $0.15 vs. price of $0.20 (33.3% above fair value)
Industry Position: 81.4% below the Medical Devices & Instruments median (#302 of 335)
No single metric tells the full story. See the ESMC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Escalon Medical Corp operates in the healthcare market, specializing in the development, manufacture, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology. Its products are A-Scans, B-Scans, UBM, Pachymeters, Ispan Intraocular Gases, Surgical Packs, Viscous Fluid Transfer Systems, and AXIS Image Management. Substantial revenue is generated from the domestic sales of products.
34GF Score
Get the complete analysis for ESMC
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ESMC has been successfully added to your 
